Mortality, Morbidity Increased With Heart Failure Hospitalization in Adults With Congenital Heart Disease
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 28, 2023 -- For adults with congenital heart disease (ACHD), those with heart failure (HF) hospitalizations have an increased risk for mortality and morbidity, according to a study published in the Dec. 5 issue of the Journal of the American Heart Association.
Pradyumna Agasthi, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues compared the outcomes of HF versus non-HF hospitalizations in ACHD. Predictors of 90-day and one-year mortality were determined, and the risks for mortality, major adverse cardiac and cerebrovascular events, and health resource use were quantified.
Data were included for 26,454 unique ACHD admissions between Jan. 1, 2010, and Dec. 31, 2020; 22 and 78 percent were hospitalized with and without HF, respectively. The researchers observed an increase from 6.6 to 10.4 percent in ACHDHF hospitalizations. During a mean follow-up of 2.23 ± 2.19 years, patients with ACHDHF hospitalizations had increased risks for mortality, major adverse cardiac and cerebrovascular events, and health resource use, including rehospitalization (hazard ratios, 1.86, 1.73, and 1.09, respectively) and increased postacute care service use (hazard ratio, 1.56). Lower 90-day and one-year mortality were seen in association with cardiology clinic visits within 30 days of hospital admission (odds ratios, 0.62 and 0.69, respectively).
"Young adults living with CHD in the United States are at increased risk of death and cardiovascular complications following hospitalization for HF," the authors write. "Those engaged in cardiology care before hospitalization have lower mortality risk, reinforcing the importance of specialist care for achieving optimal health outcomes among adults living with CHD."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Early Aortic Valve Intervention Not Beneficial for Severe Aortic Stenosis
THURSDAY, Oct. 31, 2024 -- For patients with asymptomatic severe aortic stenosis and myocardial fibrosis, early aortic valve intervention does not impact all-cause death or...
ASN: Hypertension Most Common Cardiovascular Comorbidity Seen With Dialysis
WEDNESDAY, Oct. 30, 2024 -- Hypertension is the most common cardiovascular disease (CVD) comorbidity seen among dialysis patients globally, according to a study presented at...
Knowledge of Abdominal Aortic Calcification Results Improves Some CVD Risk Factors
THURSDAY, Oct. 24, 2024 -- Providing vascular imaging results does not improve diet but does improve some cardiovascular disease risk factors at 12 weeks posttest, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.